Scott R. Tobin - 05 Nov 2025 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Nov 2025, 11:00:01 UTC
Prior SEC filing
25 Sep 2025
Next SEC filing
16 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Scott R. Tobin

Key filing fact

Scott R. Tobin filed Form 4 for CHAMPIONS ONCOLOGY, INC. (CSBR) on 07 Nov 2025.

Key facts

  • This page summarizes Scott R. Tobin's Form 4 filing for CHAMPIONS ONCOLOGY, INC. (CSBR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 07 Nov 2025, 11:00.

Change

  • Previous filing in this sequence was filed on 25 Sep 2025.
  • Current net transaction value: +$173,128.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001199926 Primary reporting owner

TOBIN SCOTT R

Relationship
Director, 10%+ Owner
Address
C/O CHAMPIONS ONCOLOGY, INC., ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK
Signature
/s/ Scott R. Tobin
Signature date
07 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSBR transaction Derivative

Option to purchase Common Stock

Award

Transaction value
$173,128
Shares
+25,460
Change %
Price
$6.80
Shares after
25,460
Date
05 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,460
Exercise price
$6.80
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .